News Release

Wednesday, March 14, 2007

Five Named to NIAID Advisory Council

The National Institute of Allergy and Infectious Diseases (NIAID) today announced the appointment of five new members to the National Advisory Allergy and Infectious Diseases Council, its principal advisory body. NIAID is part of National Institutes of Health (NIH), an agency within the Department of Health and Human Services.

The council provides recommendations on the conduct and support of research, including training young scientists and disseminating health information derived from NIAID research. It embodies a diverse perspective on science, health and the human impact of disease. The council is composed of physicians, scientists and representatives of the public who contribute their time and expertise for a four-year term.

The new council members are Robert Brooks, M.D., of the Florida State University College of Medicine; Satya Dandekar, Ph.D., from the University of California, Davis; Sharon C. Kiely, M.D., M.P.H., of Allegheny General Hospital in Pittsburgh and Drexel University School of Medicine; Marc E. Rothenberg, M.D., Ph.D., from the Cincinnati Children’s Hospital Medical Center; and David S. Wilkes, M.D., of the Indiana University School of Medicine.

Robert Brooks, M.D., is associate dean for health affairs and professor of family medicine and rural health at the Florida State University College of Medicine in Tallahassee. He serves on the Florida Governor's Health Information Technology Advisory Board and the Florida Medicaid Reform Advisory Council. Previously, he was chief of infectious diseases at the Orlando Regional Medical Center. He served in the Florida House of Representatives from 1994 until late 1998 when he was appointed Secretary of the Florida Department of Health.

Satya Dandekar, Ph.D., is professor and chair, Department of Internal Medicine, University of California, Davis. Her expertise and research interests are in the areas of HIV/AIDS. She has participated in the review of grant applications and program projects for several NIH committees and has been a scientific reviewer for numerous journals and boards. She also has been invited to lecture on clinical infectious diseases for professional organizations.

Sharon C. Kiely, M.D., M.P.H., is medical director for quality and patient safety at Allegheny General Hospital in Pittsburgh and associate professor of medicine at Drexel University School of Medicine in Philadelphia. She has served on the United Network for Organ Sharing board of directors as well as the HHS Secretary’s Advisory Committee on Xenotransplantation. She is a specialist in internal medicine and has focused her clinical, research and volunteer efforts on juvenile diabetes, medical education and care to underserved populations, including those with HIV/AIDS.

Marc E. Rothenberg, M.D., Ph.D., is professor of pediatrics and director of the Division of Allergy and Immunology at Cincinnati Children’s Hospital Medical Center. He also serves as director for the Cincinnati Center for Eosinophilic Disorders. His research focuses on molecular mechanisms of allergic inflammation. He studies the genes and molecules involved in allergic responses, cellular and molecular immunology, and the development and analysis of genetically engineered and antigen-driven models of allergic disease in mice. He also conducts translational clinical trials.

David S. Wilkes, M.D., is Dr. Calvin H. English Professor of Medicine, Microbiology and Immunology at the Indiana University School of Medicine in Indianapolis. A pulmonary and critical care physician, he is also the director for the Center for Immunobiology at Indiana. He researches the immunopathogenesis of lung transplant rejection with a focus on alloimmune-induced autoimmunity in lung transplant recipients. Dr. Wilkes has served as a NIH study section member and co-chaired the NIH-sponsored workshop on Lung Transplantation: Opportunities for Research and Clinical Advancement.

NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH…Turning Discovery Into Health®